HALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 85.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.76 | 52 Week High | $18.39 | |||
| Open | $85.76 | 52 Week Low | $6.96 | |||
| Day High | $85.76 | P/E | N/A | |||
| Day Low | $85.76 | EPS | $-0.58 | |||
| Volume | 38,108 | |||||

